Cargando…
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Despite conventionally applied postoperative radiotherapy (PORT) in pathological N2 (pN2) stage non-small cell lung cancer (NSCLC) considering high locoregional recurrence, its survival benefit has been a continuous topic of debate. Although several randomized clinical trials have been conducted, ma...
Autores principales: | Kim, Byoung Hyuck, Kim, Jae Sik, Kim, Hak Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556840/ https://www.ncbi.nlm.nih.gov/pubmed/37793623 http://dx.doi.org/10.3857/roj.2023.00430 |
Ejemplares similares
-
Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy
por: Kim, Byoung Hyuck, et al.
Publicado: (2023) -
Clinical outcomes of radical radiotherapy for pulmonary sarcomatoid carcinoma
por: Lee, Choong-won, et al.
Publicado: (2023) -
Combining radiotherapy with immunotherapy: the past, the present and the future
por: Van Limbergen, Evert J, et al.
Publicado: (2017) -
Past, present, and future of Intestinal Research
por: Cheon, Jae Hee
Publicado: (2023) -
Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)